| 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|
Operating result (€ million) | 1,021 | 885 | 858 | 749 | 728 |
IFRS net result (€ million) | 942 | 657 | 972 | 669 | 906 |
Operating return on equity (%) | 16.3 | 15.3 | 15.1 | 14.3 | 16.0 |
IFRS return on equity (%) | 15.3 | 11.7 | 19.1 | 13.7 | 21.2 |
Solvency II ratio (standard formula) (%) | 196 | 199 | 194 | 197 | 196 |
Dividend per share (€) | 2.42 | 2.04 | 1.90 | 1.74 | 1.63 |
Total dividend (€ million) | 329 | 282 | 267 | 245 | 230 |
Share buyback (€ million) | 75 | 75 | 13 | - | - |
Total equity (€ million) | 7,385 | 6,313 | 6,093 | 5,479 | 5,432 |
Total equity attributable to shareholders (€ million) | 6,363 | 5,309 | 5,089 | 4,478 | 4,432 |
Gross written premiums (€ million) | 5,859 | 5,276 | 4,666 | 4,459 | 3,920 |
New business Life segment (APE) (€ million) | 151 | 124 | 159 | 119 | 89 |
Operating expenses (€ million) | -725 | -701 | - 656 | - 601 | - 571 |
Combined ratio (Non-life segment) (%) | 91.8 | 93.6 | 93.5 | 95.7 | 95.1 |
Credit rating (S&P) | A | A | A | A | A |
Financial leverage (%) | 24.8 | 28.3 | 29.2 | 26.7 | 25.3 |
Organic capital creation (€ million) | 594 | 500 | 5011 | 372 | 377 |
Interest coverage ratio (x) | 13.8 | 9.5 | 12.9 | 10.9 | 15.6 |